Issued 2026-09-16 at $2.03 · now $2.03 (2026-09-16, +0.0% since)
Based on its own history, a month from the 2026-09-16 close, MRT has typically landed between $1.63 and $2.58 — a range of −19.8% to +27.2% from the issuance price $2.03.
- Actual close
- Typical path (median)
- Middle 50% of outcomes
- 90% range
1,246 overlapping 1 month windows · 2021-08-30 – 2026-08-17 · basis climatology · forecast (batch). Probability up 53.9% (90% CI 51.7–56.1%, ≈1,408 obs).
The cone is anchored at the 2026-09-16 issuance close ($2.03) — the price the forecast resolves against on 2026-10-15, not the latest close. The drawn path shape is illustrative (bands widen with √t); every labeled number is real — the anchor, the scored batch p90/IQR endpoints, and the typical move.
Where MRT has typically landed a month from the 2026-09-16 close of $2.03 — the range is history, not a prediction.
- now $2.03 (+0.0%)
- typicalThe typical outcome — half of similar past periods did better and half did worse (not an average, so a few wild periods don't skew it). $2.04 (+0.3%)
- middle 50%The central range of outcomes — half of similar past periods landed inside it, a quarter finished above, a quarter below. $1.99–$2.08
- 90% rangeA nine-in-ten range — in about nine of every ten similar past periods the outcome stayed within these bounds. $1.63–$2.58
| Start | Return | Max drop | Max rise |
|---|---|---|---|
| 3 worst | |||
| 2023-07-07 | −92.8% | −92.8% | +0.0% |
| 2023-07-10 | −90.5% | −90.5% | +0.0% |
| 2023-06-30 | −88.6% | −88.6% | +39.8% |
| 3 best | |||
| 2024-03-20 | +130.9% | −6.3% | +130.9% |
| 2024-03-27 | +105.4% | +0.0% | +146.5% |
| 2024-03-21 | +103.5% | −8.8% | +124.8% |
1,246 overlapping windows · 2021-08-30 – 2026-09-16 · not cherry-picked
Seasonality · by month iHow this security has tended to do in each calendar month historically — a frequency, never a prediction.
iFor each calendar month, the share of years this security closed higher than the month before, and the average month-over-month return, over ~6 years of its own price history. Cells are shaded by average return. This is historical frequency, not a prediction — no month is a signal.Up-frequency and average month-over-month return · historical frequency, not a prediction
Reported insider & political trades
Every Form 4 the people closest to this company have filed with the SEC — plotted against the share price, aggregated by month, and shown with the gap between when each trade happened and when it was disclosed. A public record, not advice.
| Date | Person | Role | Action | Shares @ price | Value | Ownership Δ | vs S&P 1m | vs S&P 6m | Owned after | Filing |
|---|
The vs-S&P columns are a labeled look-back on what the stock did after each filing, measured against the index over the same window. Descriptive history, not a claim about the person or a reason to trade.
10 award / exercise / gift records — not counted as purchases
Awards, option exercises, gifts and tax-withholding disposals are shown separately and never counted as open-market purchases or sales — they carry no conviction information.
| Date | Person | Role | Action | Shares | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-06-30 | Freifeld Daniel | director | Award / grant | 20,261 | 982,442 | Form 4 |
| 2026-06-30 | Healey Kerry Murphy | director | Award / grant | 3,732 | 240,134 | Form 4 |
| 2026-06-30 | Lute Douglas | director | Award / grant | 3,732 | 199,290 | Form 4 |
| 2026-06-30 | Ugur Agah | director | Award / grant | 3,199 | 392,039 | Form 4 |
| 2026-06-30 | Spiro Alex | director | Award / grant | 2,666 | 56,614 | Form 4 |
| 2026-03-31 | Lute Douglas | director | Award / grant | 3,732 | 195,558 | Form 4 |
| 2026-03-31 | Spiro Alex | director | Award / grant | 2,666 | 53,948 | Form 4 |
| 2026-03-31 | Freifeld Daniel | director | Award / grant | 20,261 | 962,181 | Form 4 |
| 2026-03-31 | Ugur Agah | director | Award / grant | 3,199 | 388,840 | Form 4 |
| 2026-03-31 | Healey Kerry Murphy | director | Award / grant | 3,732 | 236,402 | Form 4 |
Source: SEC Form 4 filings. Each row links to its original filing.
Across 2012–2021, stocks where a CEO, C-suite officer, or director had recently made an open-market common-stock purchase ran about +28 bp per month above the universe average (n=34,268 stock-weeks). A historical tendency, not a prediction.
Congressional disclosures
No congressional trades disclosed for this company.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.